ROME, April 03, 2026--(BUSINESS WIRE)--Regulatory News: Mexedia S.p.A. Società Benefit (Euronext Growth Paris: ALMEX, ISIN: IT0005450819), as part of the evolution path initiated in 2024 and continued ...
Challenges such as emerging technology, government regulations, workforce shortages and increasing labor costs have driven a number of health system strategic leaders to pivot their approach for 2026.
Integrated risk management (IRM) is becoming an increasingly popular term to showcase the importance of risk at the forefront of corporate governance, as well as inferring that, traditionally, these ...
Feasibility of Weekly Electronic Health Record–Embedded Patient-Reported Outcomes for Patients Starting Oral Cancer–Directed Therapy The ELAINE 2 study (ClinicalTrials.gov identifier: NCT04432454) is ...
Mexedia S.p.A. Società Benefit (Euronext Growth Paris: ALMEX, ISIN: IT0005450819), as part of the evolution path initiated in 2024 and continued in 2025, confirms its commitment to strengthening ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results